Menu
Annual · values2025202420232022202120202019
Operating Cash Flow-12.70 M USD-41.71 M USD-98.82 M USD-169.12 M USD-189.19 M USD-81.70 M USD-120.43 M USD
Depreciation & Amortization6.70 M USD8.90 M USD8.70 M USD5.93 M USD2.09 M USD1.32 M USD758000 USD
Stock-Based Compensation23.43 M USD21.03 M USD27.48 M USD42.53 M USD47.80 M USD11.00 M USD6.04 M USD
Capital Expenditures3.35 M USD2.69 M USD5.78 M USD18.30 M USD7.88 M USD2.38 M USD4.47 M USD
Cash Flow from Investing-3.35 M USD-2.66 M USD70.41 M USD-93.78 M USD-9.87 M USD-2.38 M USD-4.47 M USD
Cash Flow from Financing77.76 M USD-1.50 M USD228000 USD2.88 M USD565.69 M USD54.28 M USD324000 USD
Dividends Paid
Stock Buybacks
Free Cash Flow-16.05 M USD-44.40 M USD-104.60 M USD-187.42 M USD-197.06 M USD-84.08 M USD-124.90 M USD

Butterfly Network Inc. is a digital health company specializing in portable, semiconductor-based ultrasound technology. It develops and commercializes whole-body handheld ultrasound probes, including the Butterfly iQ+, iQ3, iQ+ Bladder for specialized bladder scanning, and iQ+ Vet for veterinary applications, all powered by patented Ultrasound-on-Chip™ technology. These single-probe devices enable real-time imaging across multiple specialties and integrate with cloud-based software, advanced AI tools like Compass AI™ for workflow management, ambient documentation, and quality assurance, as well as enterprise platforms for hospital networks. The solutions support point-of-care ultrasound (POCUS) in diverse settings, from individual practices and health systems to medical education and global health initiatives in limited-resource areas. Butterfly Network Inc. serves clinicians, healthcare providers, veterinarians, and organizations worldwide, enhancing clinical decision-making, improving efficiencies, and promoting accessible medical imaging. Founded in 2011 and headquartered in Burlington, Massachusetts, the company drives innovation in democratizing ultrasound for better patient outcomes.